Azaquinoline derivatives

US11485733B2 · kind B2 · utility

Assignee

• Bayer Animal Health GmbH · DE

Inventors

• Nils Griebenow · Milford, US
• Wei Zhuang · Monheim, DE
• Adeline Köhler · Langenfeld, DE
• Daniel KULKE · Leverkusen, DE
• Claudia Böhm · Hannover, DE
• Kirsten BÖRNGEN · Neunburg vorm Wald, DE
• Thomas ILG · Monheim, DE
• Hans-Georg Schwarz · Dorsten, DE
• Werner Hallenbach · Nordhorn, DE
• Ulrich Görgens · Ratingen, DE
• Walter Hubsch · Wuppertal, DE
• Bernd Alig · Rübhausen, DE
• Iring HEISLER · Düsseldorf, DE
• Isa Jana Irina Janssen · Wiesbaden, DE

Key dates

• Filing date: Jun 22, 2018
• Grant date: Nov 1, 2022
• Expiry date: Jun 22, 2038

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D405/12
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention covers azaquinoline compounds of general formula (I), with A being (A1) or (A2), and in which T, R1, R2, R3, R4, R5, R6 and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.